Skip to content
Screener

Sabra Healthcare SBRA Q2 2025 earnings

Reported August 4, 2025 · After market close

Revenue$189.2MBeat by $1.7M
EPS$0.38Beat by $0.01
Revenue estimate$187.5M
EPS estimate$0.37

Next report

Nov 4, 2026 (in 2 months)
Revenue estimate$234.0M
EPS estimate$0.17

Financials

Q2 2025

Income statement

See full
Revenue$189.2M+7.4%
Net income$65.5M+173%
EPS (diluted)$0.27+170%

Balance sheet

See full
Cash & equivalents$95.2M+161%
Total debt$7.8M-36.8%
Total equity$2.7B-1.8%
Total assets$5.3B-0.4%

Cash flow

See full
Operating cash flow$81.0M+1.0%

Valuation & ratios

Valuation

as of 06/30/25
See full
Market cap$4.41B+23.7%
Enterprise value$4.32B+22.1%
P/E24.2×-44.0×
P/S6×+0.7×

Profitability

See full
Net margin24.9%+17.0pp

Returns & leverage

See full
Return on equity6.7%+4.8pp
Debt / equity0×0.0×

FAQ

When did Sabra Healthcare report Q2 2025 earnings?
Sabra Healthcare (SBRA) reported Q2 2025 earnings on August 4, 2025 after market close.
What were Sabra Healthcare's Q2 2025 revenue and EPS?
Sabra Healthcare reported revenue of $189.2M and eps of $0.38 for Q2 2025.
Did Sabra Healthcare beat estimates in Q2 2025?
Revenue beat the consensus estimate of $187.5M by $1.7M. EPS beat the consensus estimate of $0.37 by $0.01.
How did Sabra Healthcare's Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 5.9% from $178.5M a year earlier and eps grew 5.6% from $0.36.
Where can I find Sabra Healthcare's Q2 2025 SEC filings?
You can read the 8-K earnings release (0001492298-25-000030) and the 10-Q periodic report (0001492298-25-000031) directly on SEC EDGAR. The filing index links above go to sec.gov.